John F. Chin
Director/Board Member bei ANTENGENE CORPORATION LIMITED
Vermögen: 233 244 $ am 31.03.2024
Profil
John F.
Chin is currently the Executive Director & Chief Business Officer at Antengene Corporation Co., Ltd.
and Antengene Corp.
Ltd.
He previously worked as the Senior Director-Corporate Accounting Management at Celgene Corp.
from 2005 to 2020.
Prior to that, he was an Associate Product Manager at Aventis Pharmaceuticals, Inc. starting in 1998.
Mr. Chin holds an MBA from Pepperdine University, which he received in 1998, and an undergraduate degree from the University of Arizona, which he received in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.11.2022 | 1 825 496 ( 0,27% ) | 233 244 $ | 31.03.2024 |
Aktive Positionen von John F. Chin
| Unternehmen | Position | Beginn |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 18.08.2020 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.10.1998 |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - |
Ehemalige bekannte Positionen von John F. Chin
| Unternehmen | Position | Ende |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von John F. Chin
| Pepperdine University | Masters Business Admin |
| University of Arizona | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
